Are miRNAs the key to retinal degeneration?

Article

Absence of a specific RNase III endonuclease in the retina causes no immediate structural abnormalities but does prompt total retinal inactivity, according to a study published in the May 7 2008 issue of the Journal of Neuroscience.

Absence of a specific RNase III endonuclease in the retina causes no immediate structural abnormalities but does prompt total retinal inactivity, according to a study published in the May 7 2008 issue of the Journal of Neuroscience.

Devid Damiani of the Neuroscience Institute, Pisa, Italy and colleagues removed one or both alleles of Dicer, essential for the production and function of mature miRNAs, from the retinas of mice embryos.

The mice with both Dicer alleles removed were born with fully formed retinas that displayed abnormally low electrical activity. By day 16, photoreceptor rosettes had formed; various retinal cell types continued to degenerate and scotopic and photopic responses to electroretinogram (ERG) testing decreased progressively at one, three and five months. Mice with a single allele of Dicer removed registered compromised ERG responses but retinas remained structurally sound throughout life. Retinas with depleted levels of Dicer had lower levels of several different miRNAs.

The researchers concluded that, since removing Dicer prompts gradual retinal degeneration in morphologically correct cells, it is possible that miRNAs are implicated in neurodegenerative disorders.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.